The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced or metastatic ovarian cancer (OC) or advanced or metastatic endometrial cancer (EC) in Germany.
patients with FIGO stage IIb-IV OC who are starting systemic treatment or
patients with recurrent/relapsed disease, who received any previous systemic anti-tumor treatment and who are now starting systemic treatment for recurrent/relapsed disease.
Locally advanced and inoperable or metastatic EC (FIGO stage III-IV) who are starting systemic first-line therapy.
Patients participating in PRO module: IC before first therapy cycle
newly diagnosed early-stage OC (FIGO stage I-IIa)
Low grade mOC OR
Early-stage EC (FIGO stage I-II)
Map coordinates are unavailable for these locations. Locations are shown below instead.
Germany